Cargando…
Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
BACKGROUND: Tumor regression of uveal melanomas (UMs) after radiotherapy has been reported as a valuable prognostic factor for metastasis and metastatic death. But its effect on prognosis is questionable. The purpose of this study was to summarize the regression features of uveal melanoma after iodi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968312/ https://www.ncbi.nlm.nih.gov/pubmed/33726696 http://dx.doi.org/10.1186/s12886-021-01898-3 |
_version_ | 1783666038729080832 |
---|---|
author | Fang, Rui Wang, Heng Li, Yang Liu, Yue-Ming Wei, Wen-Bin |
author_facet | Fang, Rui Wang, Heng Li, Yang Liu, Yue-Ming Wei, Wen-Bin |
author_sort | Fang, Rui |
collection | PubMed |
description | BACKGROUND: Tumor regression of uveal melanomas (UMs) after radiotherapy has been reported as a valuable prognostic factor for metastasis and metastatic death. But its effect on prognosis is questionable. The purpose of this study was to summarize the regression features of uveal melanoma after iodine-125 plaque brachytherapy and the relationship with prognosis. METHODS: Adult uveal melanoma patients who only received iodine-125 plaque brachytherapy between December 2009 and March 2018 at the Beijing Tongren Hospital, Capital Medical University were enrolled in this study. The regression rate was calculated as the percent change in tumor height, and each eye was classified for four main regression patterns: Decrease (D), Stable (S), Others (O), and Increase (I), according to the trend of height change. Statistical analysis was performed using one-way ANOVA and chi-square test, univariate and multivariate logistic regression, and Kaplan-Meier analysis. RESULTS: A total of 139 patients was included in the study. The median follow-up was 35 months. Regression patterns status was pattern D in 65 tumors (46.8%), pattern S in 50 tumors (36.0%), pattern O in 6 tumors (4.3%), and pattern I in 18 tumors (12.9%). Reductions of tumor mean height for each follow-up visit were 5.26% (3 months), 10.66% (6 months), 9.37% (12 months), and 14.68% (18 months). A comparison (D vs. S vs. O vs. I) revealed the preoperative height of pattern I was significantly lower than the pattern D, S and O (mean: 7.24 vs. 7.30 vs. 6.77 vs. 5.09 mm, respectively; P = 0.037). LBD (largest basal diameter) was strongly associated with the metastasis (P = 0.03). However, an association between the tumor regression and subsequent melanoma-related metastasis and mortality could not be confirmed (P = 0.66 and P = 0.27, respectively). The tumor regression rate increased with increasing tumor height (P = 0.04) and decreased with increasing of LBD (P = 0.01). CONCLUSION: Our study showed a lack of association between the prognosis and the regression of uveal melanomas following I-125 plaque radiotherapy. The LBD and original height of the tumor have predictive value in tumor regression rate, and LBD was positively associated with metastasis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-021-01898-3. |
format | Online Article Text |
id | pubmed-7968312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79683122021-03-19 Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy Fang, Rui Wang, Heng Li, Yang Liu, Yue-Ming Wei, Wen-Bin BMC Ophthalmol Research Article BACKGROUND: Tumor regression of uveal melanomas (UMs) after radiotherapy has been reported as a valuable prognostic factor for metastasis and metastatic death. But its effect on prognosis is questionable. The purpose of this study was to summarize the regression features of uveal melanoma after iodine-125 plaque brachytherapy and the relationship with prognosis. METHODS: Adult uveal melanoma patients who only received iodine-125 plaque brachytherapy between December 2009 and March 2018 at the Beijing Tongren Hospital, Capital Medical University were enrolled in this study. The regression rate was calculated as the percent change in tumor height, and each eye was classified for four main regression patterns: Decrease (D), Stable (S), Others (O), and Increase (I), according to the trend of height change. Statistical analysis was performed using one-way ANOVA and chi-square test, univariate and multivariate logistic regression, and Kaplan-Meier analysis. RESULTS: A total of 139 patients was included in the study. The median follow-up was 35 months. Regression patterns status was pattern D in 65 tumors (46.8%), pattern S in 50 tumors (36.0%), pattern O in 6 tumors (4.3%), and pattern I in 18 tumors (12.9%). Reductions of tumor mean height for each follow-up visit were 5.26% (3 months), 10.66% (6 months), 9.37% (12 months), and 14.68% (18 months). A comparison (D vs. S vs. O vs. I) revealed the preoperative height of pattern I was significantly lower than the pattern D, S and O (mean: 7.24 vs. 7.30 vs. 6.77 vs. 5.09 mm, respectively; P = 0.037). LBD (largest basal diameter) was strongly associated with the metastasis (P = 0.03). However, an association between the tumor regression and subsequent melanoma-related metastasis and mortality could not be confirmed (P = 0.66 and P = 0.27, respectively). The tumor regression rate increased with increasing tumor height (P = 0.04) and decreased with increasing of LBD (P = 0.01). CONCLUSION: Our study showed a lack of association between the prognosis and the regression of uveal melanomas following I-125 plaque radiotherapy. The LBD and original height of the tumor have predictive value in tumor regression rate, and LBD was positively associated with metastasis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-021-01898-3. BioMed Central 2021-03-16 /pmc/articles/PMC7968312/ /pubmed/33726696 http://dx.doi.org/10.1186/s12886-021-01898-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Fang, Rui Wang, Heng Li, Yang Liu, Yue-Ming Wei, Wen-Bin Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy |
title | Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy |
title_full | Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy |
title_fullStr | Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy |
title_full_unstemmed | Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy |
title_short | Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy |
title_sort | regression patterns of uveal melanoma after iodine-125 plaque brachytherapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968312/ https://www.ncbi.nlm.nih.gov/pubmed/33726696 http://dx.doi.org/10.1186/s12886-021-01898-3 |
work_keys_str_mv | AT fangrui regressionpatternsofuvealmelanomaafteriodine125plaquebrachytherapy AT wangheng regressionpatternsofuvealmelanomaafteriodine125plaquebrachytherapy AT liyang regressionpatternsofuvealmelanomaafteriodine125plaquebrachytherapy AT liuyueming regressionpatternsofuvealmelanomaafteriodine125plaquebrachytherapy AT weiwenbin regressionpatternsofuvealmelanomaafteriodine125plaquebrachytherapy |